51-Year-Old, Aadesh Shrivastava, a bollywood singer and music composer passed away on sep 5 after battling with blood cancer.
He was diagnosed with blood cancer five years ago. He had undergone chemotherapy treatment and battled it bravely in 2011. But unfortunately, he had of relapse of the cancer recently and was critically admitted to the Kokilaben Dhirubhai Ambani hospital in Mumbai.
AdvertisementHe had been administered chemotherapy treatment for over 40 days at the hospital. But he stopped responding to the treatment and died in the midnight at 12.30 am in the hospital.
"Mr Aadesh Shrivastava (51) expired at 12.30 am on September 5, 2015 in Kokilaben Hospital due to cancer," said Dr Ram Narain.
Last evening Shrivastava's brother-in-law and composer Lalit Pandit said, "He has been undergoing chemotherapy but he is not responding to it. So, the doctors have stopped giving him chemotherapy. They have an alternate theory. The doctors are trying to do their best and Aadesh is fighting it bravely."
Many people from the Bollywood film fraternity has offered their condolences to the late music director through calls and social media.
"Terrible. Terrible. Terrible News. Too young to Go Aadesh Shrivastava," film director Anubhav Sinha said on Twitter. Over the course of his career, Shrivastava had composed music for over 100 Hindi films.
His colleagues from the industry, including Amitabh Bachchan and Shah Rukh Khan, were keeping a check on his health.
"Amit ji (Amitabh Bachchan) has been keeping a check on his health regularly over phone. He has been very helpful. Besides, Shah Rukh Khan had come to visit him too. Tina Ambani has visited him twice and she is also taking special care," said Lalit.
"People from the music industry like Shaan, Sonu Nigam, Kumar Sanu, Alka Yagnik and Udit Narayan also have been visiting him regularly. Shekar Kapur, Govind Nihalani, Poonam Dhillon and others had come to see him too," he said.
PSwiss Drug Firm Collaborates With Amgen to Develop Treatments for Alzheimer's Disease Reimbursement of Drug for Multiple Sclerosis Agreed by Health Service Executive, Ireland M
You May Also Like